News – Page 1126 – Endpoints News

Esperion shares surge after execs say the FDA indicates its LDL pill could be ready to roll in 2019

9 years ago

Aevi shares smashed by a trial failure for ADHD genetic subgroup

9 years ago

Laggard Lilly says its CDK 4/6 drug abemaciclib scored in PhIII, while rivals at Novartis, Pfizer sharpen their ...

9 years ago

Want to buy a pain therapy? Nektar lays out a PhIII sales pitch

9 years ago

CTLA-4 bound for the clinic, Bristol-Myers hands CytomX $200M to kick off an expanded discovery pact

9 years ago

Array walks back its FDA pitch on binimetinib, derailing plans for commercial launch

9 years ago

AveXis shares spike on more positive data for SMA gene therapy; Biogen stock tanks on fresh skepticism

9 years ago

Trump needs to prove he's serious about science; PTC's latest move is a jaw dropper

9 years ago

Heart attack while on Repatha? Amgen will give you your money back

9 years ago

Texas biotech executes a reverse merger with a battered Threshold

9 years ago

Circassia forges a $300M COPD sales/development pact for US rights on two AstraZeneca drugs

9 years ago

AstraZeneca ordered back into the penalty box on ZS-9 after another rejection on manufacturing malfunction

9 years ago

Biogen recruits Roche vet Ghosh as head of research, early development; Cell Medica raises £60 million; Aerpio bags ...

9 years ago

After being spurned at the FDA, PTC buys a controversial Duchenne MD therapy from Marathon

9 years ago

New biotech venture fund debuts with $300M for a mix of US and European players

9 years ago

Trump’s budget takes a big bite out of the NIH, with big new fees for biopharma

9 years ago

Seres doubles down on a microbiome do-over as the FDA clears a make-or-break study

9 years ago

Armed with CRISPR and a $38M round, eGenesis tackles the Holy Grail of xenotransplantation

9 years ago

Sanders, Cummings probing FDA’s handling of Marathon after a controversial OK of old steroid for Duchenne MD

9 years ago

Clozel’s Actelion R&D spinout gets a name; GSK’s new CEO won’t make as much as her predecessor

9 years ago

Catalyst shares jazzed by a new round of positive results for a rare neuromuscular disease

9 years ago

Immunomedics lays out its case for an accelerated OK of IMMU-132 in triple-negative breast cancer

9 years ago

Gates vets raise a $200M life sci fund for avant-garde genomic biotechs and digital health players

9 years ago

FDA OKs Merck’s Keytruda for Hodgkin lymphoma, a first in blood cancer

9 years ago

First page Previous page 1123 1124 112511261127 1128 1129 Next page Last page